Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Bron, 69677, France
NCT Number: NCT03281564
A lot of patients seem to complain after hysteroscopic tubal occlusion by Essure® device with a worce quality of life. Investigators' hypothesis is that Essure® laparoscopic removal may improve quality of life. This prospectice study aim to assess the quality of life 1, 3, 6 and 12 months after Essure® removal.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Bron, 69677, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaire to assess the quality of life 1, 3, 6 and 12 months after laparoscopic removal of Essure® device
Time frame: 1 month
Questionnaire to assess the quality of life 1 month after laparoscopic removal of Essure® device
Hospices Civils de Lyon
Other
Prospective Study of Quality of Life After Laparoscopic Removal of Essure®
Acronym: ABLIMCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03623126
Contraceptive Device; Complications, Quality of Life
Lyon, France
View Trial DetailsNCT07264933
Cesarean Section Complications, Contraceptive Device; Complications
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsNCT06000423
Bleeding, Contraceptive Device; Complications
Portland, Oregon, United States
View Trial DetailsNCT03438682
Contraception, Contraceptive Device; Complications
New Haven, Connecticut, United States
View Trial Details